- Home
- SGMO vs CSTE Comparison
SGMO vs CSTE Comparison
Compare SGMO & CSTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMO
- CSTE
- Stock Information
- Founded
- SGMO 1995
- CSTE 1987
- Country
- SGMO United States
- CSTE Israel
- Employees
- SGMO N/A
- CSTE N/A
- Industry
- SGMO Biotechnology: Biological Products (No Diagnostic Substances)
- CSTE Building Materials
- Sector
- SGMO Health Care
- CSTE Industrials
- Exchange
- SGMO Nasdaq
- CSTE Nasdaq
- Market Cap
- SGMO 180.5M
- CSTE 152.7M
- IPO Year
- SGMO 2000
- CSTE 2012
- Fundamental
- Price
- SGMO $1.96
- CSTE $3.98
- Analyst Decision
- SGMO Buy
- CSTE Buy
- Analyst Count
- SGMO 3
- CSTE 2
- Target Price
- SGMO $7.00
- CSTE $5.50
- AVG Volume (30 Days)
- SGMO 11.1M
- CSTE 44.4K
- Earning Date
- SGMO 11-12-2024
- CSTE 11-13-2024
- Dividend Yield
- SGMO N/A
- CSTE N/A
- EPS Growth
- SGMO N/A
- CSTE N/A
- EPS
- SGMO N/A
- CSTE N/A
- Revenue
- SGMO $52,291,000.00
- CSTE $473,883,000.00
- Revenue This Year
- SGMO N/A
- CSTE N/A
- Revenue Next Year
- SGMO $71.79
- CSTE N/A
- P/E Ratio
- SGMO N/A
- CSTE N/A
- Revenue Growth
- SGMO N/A
- CSTE N/A
- 52 Week Low
- SGMO $0.30
- CSTE $3.50
- 52 Week High
- SGMO $3.18
- CSTE $6.81
- Technical
- Relative Strength Index (RSI)
- SGMO 51.89
- CSTE 43.61
- Support Level
- SGMO $1.82
- CSTE $3.82
- Resistance Level
- SGMO $2.11
- CSTE $4.12
- Average True Range (ATR)
- SGMO 0.38
- CSTE 0.21
- MACD
- SGMO -0.10
- CSTE -0.01
- Stochastic Oscillator
- SGMO 16.44
- CSTE 23.38
About SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).